[go: up one dir, main page]

CR20160116A - Método para tratar onicomicosis con hidroxipropil quitasano - Google Patents

Método para tratar onicomicosis con hidroxipropil quitasano

Info

Publication number
CR20160116A
CR20160116A CR20160116A CR20160116A CR20160116A CR 20160116 A CR20160116 A CR 20160116A CR 20160116 A CR20160116 A CR 20160116A CR 20160116 A CR20160116 A CR 20160116A CR 20160116 A CR20160116 A CR 20160116A
Authority
CR
Costa Rica
Prior art keywords
quitasan
onycomycosis
hydroxipropil
treat
hydroxypropyl chitosan
Prior art date
Application number
CR20160116A
Other languages
English (en)
Inventor
Federico Mailland
Maurizio Caserini
Daniela Ceriani
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49118439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20160116(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of CR20160116A publication Critical patent/CR20160116A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invención está dirigida a un método para el tratamiento de onicomicosis mediante la administración tópica de una composición que contiene hidroxipropil quitosano como único ingrediente activo y, en particular, mediante la administración de una composición tópica para las uñas que consiste esencialmente en:a) hidroxipropil quitosano,b) agua,c) al menos un alcanol inferior.
CR20160116A 2013-09-10 2016-03-07 Método para tratar onicomicosis con hidroxipropil quitasano CR20160116A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13183789.0A EP2845597A1 (en) 2013-09-10 2013-09-10 Hydroxypropyl chitosan for the treatment of onychomycosis
PCT/EP2014/069099 WO2015036369A1 (en) 2013-09-10 2014-09-08 Method to treat onychomycosis by hydroxypropyl chitosan

Publications (1)

Publication Number Publication Date
CR20160116A true CR20160116A (es) 2016-06-14

Family

ID=49118439

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160116A CR20160116A (es) 2013-09-10 2016-03-07 Método para tratar onicomicosis con hidroxipropil quitasano

Country Status (20)

Country Link
US (1) US20160213705A1 (es)
EP (2) EP2845597A1 (es)
JP (1) JP2016529326A (es)
KR (1) KR20160051751A (es)
CN (1) CN105579047A (es)
AU (1) AU2014320473A1 (es)
CA (1) CA2922236A1 (es)
CL (1) CL2016000542A1 (es)
CR (1) CR20160116A (es)
EA (1) EA201690551A1 (es)
HK (1) HK1223042A1 (es)
IL (1) IL244423A0 (es)
MA (1) MA38896A1 (es)
MD (1) MD20160039A2 (es)
MX (1) MX2016003122A (es)
PE (1) PE20160530A1 (es)
PH (1) PH12016500471A1 (es)
SG (1) SG11201601200SA (es)
TN (1) TN2016000054A1 (es)
WO (1) WO2015036369A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2704782C1 (ru) * 2018-10-09 2019-10-30 Елена Владимировна Герасимчук Способ криогенного лечения онихомикоза

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
EP1491202A1 (en) * 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
EP1958638A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate

Also Published As

Publication number Publication date
JP2016529326A (ja) 2016-09-23
EP3043804A1 (en) 2016-07-20
MA38896A1 (fr) 2018-03-30
SG11201601200SA (en) 2016-03-30
EA201690551A1 (ru) 2016-07-29
CN105579047A (zh) 2016-05-11
MD20160039A2 (ro) 2016-07-31
PH12016500471A1 (en) 2016-05-16
IL244423A0 (en) 2016-04-21
AU2014320473A1 (en) 2016-03-24
TN2016000054A1 (en) 2017-07-05
PE20160530A1 (es) 2016-05-21
EP2845597A1 (en) 2015-03-11
CA2922236A1 (en) 2015-03-19
CL2016000542A1 (es) 2016-10-07
US20160213705A1 (en) 2016-07-28
KR20160051751A (ko) 2016-05-11
MX2016003122A (es) 2016-11-14
HK1223042A1 (zh) 2017-07-21
WO2015036369A1 (en) 2015-03-19

Similar Documents

Publication Publication Date Title
CO2018001375A2 (es) Composiciones de retinoides tópicos
CO6821938A2 (es) Un compuesto de guanidina o una sal del mismo para el tratamiento de enfermedades relacionadas con vap -1
CO2017001493A2 (es) Kits que comprenden inhibidores tigit y agentes anticáncer
NI201700135A (es) Derivados de ciclohexano sustituido con amido
CR20160200A (es) Combinaciones de inhibidores de histona desacetilasa y fármacos inmunomoduladores
ECSP15030799A (es) Compuestos sustituidos de pirrolopirimidina, composiciones de los mismos, y métodos de tratamiento con los mismos
MX391858B (es) Compuestos terapeuticamente activos y sus metodos de uso
MX370664B (es) Inhibidores de la proteína regulada por glucosa 94 (gpr94) selectivos y usos de los mismos.
GT201400003A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
MX2016011842A (es) Composiciones tópicas de corticosteroides.
CO7131352A2 (es) Composiciones farmacéuticas tópicas
MX2015012273A (es) Composicion farmaceutica para el tratamiento de infecciones micoticas.
CO7141430A2 (es) Formulaciones vesiculares para uso en el tratamiento del dolor o movilidad reducida de una articulación
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
MX2018007871A (es) Composiciones para el cuidado personal.
DOP2016000007A (es) Pirazolpiridinas sustituidas
MX2018005796A (es) Reduccion de la sensacion de picazon en la piel.
BR112015029894A2 (pt) forma de dosagem farmacêutica sólida
ECSP15033898A (es) Composición antifúngica tópica para el tratamiento de onicomicosis
UY35695A (es) Composicion para el tratamiento contra el envejecimiento de la piel
MX386144B (es) Inmunopotenciador.
AR094224A1 (es) Composicion farmaceutica en forma de una suspension oral
CR20160116A (es) Método para tratar onicomicosis con hidroxipropil quitasano
NI201200196A (es) Agentes terapéuticos 976
MX2015008104A (es) Uso de pidotimod para tratar la psoriasis.